Merck to buy Prometheus Biosciences for about $11 bln : vima

Merck & Co has agreed to
acquire Prometheus Biosciences Inc for about $10.8
billion to bolster the company's presence in immunology, the
companies said on Sunday.
The joint statement... | April 16, 2023

Related Keywords

Bengaluru , Karnataka , India , David Goodman , Akanksha Khushi , Tom Hogue , Robert Davis , Kanjyik Ghosh , Merck Co , Reuters , Prometheus Biosciences Inc , Merck Chairman , Chief Executive Robert , Wall Street Journal , Wall Street , Bengaluru Editing , Prometheus Biosciences , Nc Stock Exchange , News , Information , Press Release , Merck , O , Gas , Greed , Prometheus , Iosciences , Nc , Or , Bout , Holster , The , Presence , N , Aid , Oint Rxdx Us74349u1088 ,